Rendering a drug effective or ineffective in a flash at the appropriate location—this is the focus of research in photopharmacology. The goal is to develop drugs that can be switched on and off with ...

Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...

Matthew Herper covers medical innovation — both its promise and its perils. SAN FRANCISCO — On Sunday, Alnylam, the gene-silencing company that notched one gigantic accomplishment after another over ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...

epocrates, a drug reference and clinical decision-support app, developed an AI assistant feature that gives clinicians quick, concise answers about prescription medications to aid in clinical decision ...

In 1962, the Congress vested the Food and Drug Administration (FDA) with the authority to regulate prescription drug advertising. These advertisements can mislead the public about the risks and ...

Please provide your email address to receive an email when new articles are posted on . Healio Clinical Guidance announced the launch of Drug Lookup, a free tool that provides quick access to drug ...

Floyd Howard Jr. calls it his comfort zone — a canopy-covered courtyard in the heart of Skid Row where he can charge his phone, smoke a cigarette and catch up with friends. It's also the centerpiece ...

This premium article is for members. If you are one, please sign in. You have two free premium articles remaining. To become a member, subscribe today. Our journalism relies on member support.

Microdosing GLP-1 (glucagon-like peptide-1) agonist weight loss drugs involves taking smaller doses of semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) than recommended by the U.S.